September 2024

KDIGO is updating The 2021 Clinical Practice Guideline for the Management of Glomerular Diseases on an ongoing, chapter-by-chapter basis. The KDIGO 2024 Clinical Practice Guideline for the Management of IgA Nephropathy (IgAN) and IgA Vasculitis (IgAV) is available for public review through Monday, September 30. The update takes into consideration evidence from randomized controlled trials published through April 2023. Based on the feedback received during this open comment period, a final revised version will be prepared for publication. Brad Rovin, MD (United States), and Jürgen Floege, MD (Germany) co-chaired the guideline chapter updates and the 2021 KDIGO Glomerular Diseases Guideline.

KDIGO invites the public to review this chapter update and share candid comments and suggestions. Download the KDIGO IgAN/IgAV Guideline Public Review Draft and provide comments via the feedback survey one the KDIGO IgAN/IgAV website.

A Case-Based Look at Recognizing, Diagnosing, and Managing Anemia Earlier in CKD

CME/CNE Webinar

Thursday, September 26, 12:00 - 12:30 PM ET

Join us for a symposium on dialysis-dependent (DD) chronic kidney disease (CKD) anemia designed to encourage the exchange of ideas between leaders in the field and attendees. This webinar, led by Matthew Weir, MD (United States), will address the role of hypoxia-inducible factor prolyl-hydroxylase inhibitors (HIF-PHIs) for the treatment of DD-CKD anemia, and when it is appropriate to use HIF-PHIs in the treatment of DD-CKD anemia. Register.

KDIGO at the 2024 EDTNA/ERCA International Conference

Athens, Greece

September 23, 11:00 AM - 12:30 PM

Are you attending the 52nd EDTNA/ERCA International Conference in Athens, Greece? Don't miss the KDIGO session, "Easing the Symptom Burden of People with Kidney Failure: The Vital Role of Nurses in Dialysis," on Monday, September 23, at 11:00 AM. The session focuses on the pivotal role played by nurses in managing dialysis symptoms. It will address how to identify the burden of dialysis symptoms for people and caregivers of people receiving dialysis and how to improve the management of dialysis symptoms. Learn more.

KDIGO at the XXXII Congresso Brasileiro de Nefrologia

Salvador, Brazil

September 25, 9:00 AM - 6:00 PM

September 26, 4:50 - 6:20 PM

September 27, 10:30 AM - 12:30 PM

KDIGO is excited to attend the 2024 Brazilian Congress of Nephrology in Salvador, Brazil, and for multiple KDIGO events. Don't miss "KDIGO-ISN-BSN Workshop: Advancing CKD Management with Evidence-Based Guidelines," on September 25, 9:00 AM to 6:00 PM. The workshop features an impressive panel of local and global experts covering topics related to the latest science and guidance from the KDIGO 2024 CKD Guideline.

KDIGO will also have two sessions at the congress, including "KDIGO Updates on the Management of Glomerular Disease" on September 26, from 4:50 PM to 6:20 PM, and "KDIGO Clinical Practice Guideline for Acute Kidney Injury (AKI) and Acute Kidney Disease (AKD) – Update 2024," on September 27, from 10:30 AM to 12:00 PM. Learn more.

29th Wonca Europe Conference

Dublin, Ireland

September 25 - 28

Will you be in Dubin, Ireland for the 29th Wonca Europe Conference? Make sure to swing by the KDIGO booth to say hello and pick up new nephrology resources for primary care physicians. Learn more.

ISPD 2024 Congress

Dubai, United Arab Emirates

September 28, from 09:15 - 10:45 AM

If you are attending the 2024 ISPD Congress in Dubai, United Arab Emirates, don't miss the KDIGO session on Saturday, September 28, from 09:15 to 10:45 AM. Rajnish Mehrotra, MD (United States) will present "Incorporating Symptom and QOL Assessment in Routine PD Care," and Magdelena Madero, MD (Mexico) will present "Managing Common Symptoms in Dialysis Patients." Learn more.

New Resources

HIF PHIs: Revisiting Mechanisms That Matter in Anemia

On-Demand CME/CNE Webinar

Check out "HIF PHIs: Revisiting Mechanisms That Matter in Anemia," now available on-demand!

In this CME webinar, Professor Wolfgang Winkelmayer, MD (United States) discusses the clinical data of a newly approved class of therapeutic agents called hypoxia-inducible factor prolyl-hydroxylase inhibitors (HIF-PHIs) for patients with anemia of dialysis-dependent chronic kidney disease (DD-CKD). Learn how these new therapies fit into current treatment paradigms, and hear about anticipated updates to the KDIGO Anemia Guideline. Watch the webinar.

Curbside Consult: Optimizing IgAN Management

On-Demand CME/CE Webinar

How can we optimize outcomes for patients with IgAN and prevent them from progressing to kidney failure? Join Khalil El Karoui, MD (France) and Federico Alberici, MD (Italy) as they review a real-world IgAN case demonstrating the limitations of current therapies and the promising potential of emerging treatments. They will also discuss the role of proteinuria in predicting disease outcomes and informing treatment. Watch the webinar.

Why We Should Be PRO Patients With CKD-Associated Pruritus

On-Demand CME/CE Webinar

How can we optimize outcomes for patients with chronic kidney disease-associated pruritus, or CKD-aP? In this free CME webinar, Lucio Manenti, MD (Italy), Jeanette Finderup, PhD (Denmark), and Sebastian Koball, MD (Germany) discuss how to implement a multidisciplinary team approach and seamlessly integrate Patient-Reported Outcome Measures, or PROMS, into clinical practice.  Watch the webinar.

Optimizing the Holistic Approach to CKD Evaluation & Management Webinar Series

On-Demand Webinar Series

This five-part webinar series explores the holistic approach to CKD evaluation and management and is based on The KDIGO 2024 CKD Guideline.  The webinar series features an extraordinary panel of global experts, including the CKD Guideline Co-Chairs and several Work Group Members. Watch the webinar series.

About KDIGO

KDIGO is a Belgian foundation committed to developing and implementing nephrology guidelines that improve outcomes for people with kidney disease on a global basis. KDIGO is independent, volunteer-led, self-managed, and accountable to the public and the people it serves. Learn more.